Fake drugs cost EU pharma €10.2bn, says report

29-09-2016

Fake drugs cost EU pharma €10.2bn, says report

EM Karuna / shutterstock.com

Fake drugs cost EU pharmaceutical companies up to €10.2 billion ($11.4 billion) annually, a new report from the European Union Intellectual Property Office (EUIPO) has revealed.


Counterfeit drugs, IP, infringement, EUIPO, report, The Economic Cost of IPR Infringement in the Pharmaceutical Industry

LSIPR